NCT03621683 is a NA clinical trial of blood rich plasma platelets in Ovarian Reserve, sponsored by Lucy Coleman.

Who is sponsoring NCT03621683?

NCT03621683 is sponsored by Lucy Coleman.

What drugs are being tested in NCT03621683?

Interventions in NCT03621683: blood rich plasma platelets, Antioxidant therapy.

What condition does NCT03621683 study?

NCT03621683 studies Ovarian Reserve.

Is NCT03621683 still recruiting?

NCT03621683 is currently completed. Last updated 8 August 2018.

Last reviewed 2018-08-08 · How we verify

NCT03621683

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Antioxidants vs. Ovarian Bio-stimulation Therapy to Rescue the Ovarian Reserve

Completed NA Last updated 8 August 2018

What this trial tests

NA trial testing blood rich plasma platelets in Ovarian Reserve in 78 participants. Completed in 28 August 2017.

Timeline

6 January 2016

Primary endpoint
10 January 2017

28 August 2017

Quick facts

Lead sponsor	Lucy Coleman
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	78
Start date	6 January 2016
Primary completion	10 January 2017
Estimated completion	28 August 2017
Sites	1 location across Venezuela

Drugs / interventions tested

blood rich plasma platelets
Antioxidant therapy — full drug profile →

Conditions studied

Ovarian Reserve — all drugs for Ovarian Reserve →

Sponsor

Lucy Coleman

Who can join

Adults 38 to 46, female only, with Ovarian Reserve. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Two group of patients were selected. Group 1 represents 46 patients that received ovarian-biostimulation monthly for three months. Group 2 represents 32 patients that received antioxidant therapy daily for 3 months. Results are noted and analysed. Both groups represent patients with procedures already ongoing, and with diagnosed poor or depleted ovarian reserve. The analysis has been made to compare the efficacy of both procedures.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Ovarian Reserve

Currently open trials in the same condition.

NCT07469007 — Impact of Surgery for Deep Posterior Endometriosis on Ovarian Reserve (ENDORO) · NA · recruiting
NCT06626282 — Fertility and Ovarian Reserve in Female Childhood Cancer Survivors · recruiting
NCT06633120 — In Vitro Maturation of Human Eggs · NA · recruiting
NCT04487925 — Controlled Ovarian Stimulation Versus Modified Natural Cycles in Poor Responders · Phase 4 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03621683 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Lucy Coleman
Last refreshed: 8 August 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03621683.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing